Bhavini Patel Murthy

TL;DR: The U.S. CDC social vulnerability index (SVI) as discussed by the authors uses 15 indicators grouped into four themes that comprise an overall SVI measure, resulting in 20 metrics, each of which has national and state-specific county rankings.

TL;DR: In this article, the authors analyzed county-level vaccine administration data among adults aged ≥18 years who received their first dose of either the Pfizer-BioNTech or Moderna COVID-19 vaccine, or a single dose of the Janssen COVID19 vaccine (Johnson & Johnson) during December 14-April 10, 2021 in 50 U.S. jurisdictions (49 states and the District of Columbia [DC]).

TL;DR: Compared with estimates from a previous study of vaccine coverage among adults aged ≥18 years during December 14, 2020-April 10, 2021, these urban-rural disparities among those now eligible for vaccination (aged ≥5 years) have increased more than twofold through January 2022, despite increased availability and access to COVID-19 vaccines.

TL;DR: In the first phase of the U.S. COVID-19 vaccination program as discussed by the authors, two vaccines (Pfizer-BioNTech and Moderna) were authorized for emergency use in the United States for the prevention of coronavirus disease 2019.

TL;DR: In this paper, the effectiveness of COVID-19-associated hospitalization among adults aged 65-74 years was evaluated using data collected from the COVID19-Associated Hospitalization Surveillance Network (COVID-NET) for the catchment area (approximately 4.8 million persons).